Philadelphia Financial Management of San Francisco LLC Purchases Shares of 1,343,007 ASP Isotopes Inc. $ASPI

Philadelphia Financial Management of San Francisco LLC acquired a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 1,343,007 shares of the company’s stock, valued at approximately $8,353,504,000. ASP Isotopes accounts for about 1.7% of Philadelphia Financial Management of San Francisco LLC’s investment portfolio, making the stock its 19th largest holding.

A number of other large investors have also recently made changes to their positions in ASPI. Mercer Global Advisors Inc. ADV lifted its position in shares of ASP Isotopes by 8.3% during the third quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock worth $203,000 after purchasing an additional 1,622 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in ASP Isotopes by 9.9% in the second quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock worth $153,000 after purchasing an additional 1,878 shares in the last quarter. Legal & General Group Plc lifted its holdings in shares of ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after purchasing an additional 1,953 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of ASP Isotopes by 8.8% during the first quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company’s stock valued at $135,000 after acquiring an additional 2,470 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its holdings in shares of ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after acquiring an additional 2,548 shares in the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Stock Performance

Shares of ASP Isotopes stock opened at $3.94 on Thursday. The business’s 50 day moving average price is $4.78 and its 200 day moving average price is $5.27. The company has a market cap of $604.04 million, a price-to-earnings ratio of -2.98 and a beta of 3.61. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87. ASP Isotopes Inc. has a one year low of $3.51 and a one year high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last issued its earnings results on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The company had revenue of $5.12 million during the quarter, compared to analyst estimates of $4.47 million.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ASPI. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $13.00.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, CFO Heather Kiessling sold 23,124 shares of ASP Isotopes stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $6.28, for a total transaction of $145,218.72. Following the transaction, the chief financial officer directly owned 1,526,252 shares of the company’s stock, valued at $9,584,862.56. The trade was a 1.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Michael Gorley sold 30,000 shares of the business’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $6.27, for a total transaction of $188,100.00. Following the completion of the transaction, the director owned 87,908 shares in the company, valued at $551,183.16. The trade was a 25.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 279,079 shares of company stock valued at $2,049,208 in the last three months. 14.40% of the stock is currently owned by corporate insiders.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.